Ankur Dhanik

1 paper in the catalog · USA

Ankur Dhanik: 1 paper in the catalog · USA · Regeneron Pharmaceuticals, Inc. · Works on CRC liver metastasis neoantigen discovery

Affiliations

• Regeneron Pharmaceuticals, Inc.

Elsewhere

ORCID 0000-0001-9692-6980 · OpenAlex

Papers

• Proteogenomics and de novo sequencing based approach for neoantigen discovery from the immunopeptidomes of patient CRC liver metastases using Mass Spectrometry (2020, The Journal of Immunology)

Methods and tools

CRC liver metastasis neoantigen discovery

Patents (1)

• US20240153587A1 Workflow to assign putative source to de novo peptide sequence ↗ (Regeneron Pharmaceuticals, Inc., priority 2021-03-11, pending)

Patent families naming this author as an inventor. The link is made only where the same person is evident: they wrote a paper describing the patented method, or worked at the assignee.

Co-authors (6)

Ranked by Newman fractional collaboration strength, so a pair on a two-author paper counts for more than a pair on a 50-author consortium paper.

• Anna Rye-Weller strength 0.17, 1 shared
• Darshit shah strength 0.17, 1 shared
• Kamil Cygan strength 0.17, 1 shared
• Olav Olsen strength 0.17, 1 shared
• Robert Salzler strength 0.17, 1 shared
• William Olson strength 0.17, 1 shared

Seen in the charts

• Browse all authors
• Where the work happens

Back to the full map